Dental Bone Graft And Substitutes Market to Witness Soaring Growth During 2021 – 2028

 Dental Bone Graft And Substitutes Market Growth & Trends

The global dental bone graft and substitutes market size is expected to reach USD 1.3 billion by 2028 registering a CAGR of 11.4%, according to a new report by Grand View Research, Inc. The increasing number of dental implant surgeries, the growing target population, and new product launches are the major growth propelling factors for the market. According to the Population Reference Bureau 2018 statistics, by 2050, from 13 countries to around 82 countries across the world are anticipated to have more than 20% of the geriatric population. Thus, perpetual growth in the population aged 60 years and above is anticipated to result in an increased prevalence of periodontal diseases.

Moreover, the rising adoption of synthetic bone grafts over autografts and allografts due to advantages, such as lesser chances of disease transmission, is further propelling the market growth. The growing medical tourism sector in developing countries is another factor driving the market. Countries, such as South Korea, India, and Turkey, are constantly gaining popularity in dental tourism due to cheaper costs and advanced treatment options. In addition, the rising number of periodontists and oral surgeons is boosting the market growth.

Request a free sample copy or view report summary: Dental Bone Graft And Substitutes Market Report

Dental Bone Graft And Substitutes Market Report Highlights

• The synthetic material type is expected to be the fastest-growing segment over the forecast period owing to its better acceptance and reduced risk of disease transmission
• Socket preservation application segment held the largest market in 2020 owing to the increasing number of dental implant surgeries and growing concerns regarding dental health
• The dental clinic end-use segment is expected to account for the maximum revenue share of the global market by 2028 due to the availability of surgeons and advanced treatment options offered in dental clinics
• Asia Pacific is expected to emerge as the fastest-growing regional market from 2021 to 2028 owing to the rapidly expanding medical tourism sector and growing disposable income
• Europe held the largest share in 2020 due to the increased number of dental implant surgeries in this region; however, North America is estimated to lead the market, in terms of revenue share, during the forecast period

Dental Bone Graft And Substitutes Market Segmentation

Grand View Research has segmented the global dental bone graft and substitutes market on the basis of material type, application, end-use, and region:

Dental Bone Graft And Substitutes Material Type Outlook (Revenue, USD Million, 2016 - 2028)

• Allograft
  • Demineralized Bone Matrix
  • Others
• Autograft
• Xenograft
• Synthetic

Dental Bone Graft And Substitutes Application Outlook (Revenue, USD Million, 2016 - 2028)

• Ridge Augmentation
• Sinus Lift
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Socket Preservation

Dental Bone Graft And Substitutes End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Dental Clinics

Dental Bone Graft And Substitutes Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Dental Bone Graft And Substitutes Market

• Institut Straumann AG
• Dentsply Sirona
• Medtronic PLC
• Zimmer Biomet
• RTI Surgical, Inc.
• Geistlich Pharma AG
• BioHorizons
• Orthogen
• Dentium Co., Ltd.
• LifeNet Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Product Design & Development Services Market Current And Future Market Conditions 2021-2028: Grand View Research Inc.

 Product Design And Development Services Market Growth & Trends

The global product design and development services market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Low product cost, short time-to-market, and demand for advanced technologies are some of the factors boosting the growth. Medical and life sciences companies face extreme cost pressures to develop new and innovative products in shorter time frames while complying with stringent regulatory requirements of medical device.

The manufacturers face more hurdles in getting cost-effective high-quality products to market faster along with some internal factors, such as designing and production. Hence, medical device companies adopt a design-to-manufacturing approach where design, engineering, as well as production teams work in collaboration to develop the product model. This approach enhances both product quality and profitability by decreasing errors in development and designing thereby increasing success rates.

Outsourcing design engineering is anticipated to witness healthy growth over the forecast period as an increased number of manufacturers—from start-up ventures to established companies—capitalize on the benefits related to outsourcing design engineering such as improved product design and cost-effectiveness to attain a competitive edge. Furthermore, with the incorporation of IT into healthcare industry, analysis on 3D models and software, for which the third parties are well trained are expected to promote growth.

However, COVID-19 has added complexity and challenge to the medical device innovation. The product development firms are facing the major challenges so far as how to continue with business operations while evading the effects of the crisis. Product development during the pandemic continues to show optimal scope. The huge cost of development, financial risks of missing the mark, and market timing altogether contribute to the greatest challenges of medical device development and market driving innovation.

Request a free sample copy or view report summary: Product Design And Development Services Market Report

Product Design & Development Services Market Report Highlights

• The research, strategy, and concept generation services segment accounted for the highest revenue share of 39.9% in 2020 as the stage requires extensive research and business and design strategy that generate maximum revenue
• The surgical instruments segment held major market share of 27.9% in 2020, due to the complexity of instruments which require detailed designing for making them suitable for direct contact with human body
• Key players in emerging economies of Asia Pacific and Latin America are witnessing significant increase in their revenue owing to the presence of lucrative growth opportunities
• Medical device Original Equipment Manufacturers (OEMs) are outsourcing the production of their devices to developing economies due to availability of labor and raw materials at affordable cost

Product Design & Development Services Market Segmentation

Grand View Research has segmented the global product design and development services market based on services, application, end use, and region:

Product Design And Development Services Outlook (Revenue, USD Million, 2016 - 2028)

• Research, Strategy, & Concept Generation
• Concept & Requirements Development
• Detailed Design & Process Development
• Design Verification
• Process Validation, Manufacturing Transfer & Design Validation
• Production & Commercial Support

Product Design And Development Services Application Outlook (Revenue, USD Million, 2016 - 2028)

• Diagnostic Equipment
• Therapeutic Equipment
• Surgical Instruments
• Clinical Laboratory Equipment
• Biological Storage
• Consumables
• Others

Product Design And Development Services End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations

Product Design And Development Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Ukraine
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South KoreaIndonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

List of Key Players of Product Design And Development Services Market

• Ximedica
• DeviceLab Inc.
• Jabil Inc.
• Flex Ltd.
• Plexus Corp.
• Celestica Inc.
• Starfish Medical
• Nordson Medical
• Planet Innovation
• Donatelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wound Irrigation System Market Size Is Expected To Reach USD 380.03 Million by 2028

 Wound Irrigation System Market Growth & Trends

The global wound irrigation system market size is expected to reach USD 380.03 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.8% from 2021 to 2028. The rising prevalence of chronic wounds, increasing number of surgical procedures, technological advancements, favorable initiatives taken by the private and public sectors, and the increasing cases of burns across the globe are the key factors driving the market.

A wound irrigation system allows rapid healing of deep wounds and surgical site infections. It also allows improved wound cleansing that prevents further complications. The increasing prevalence of chronic wounds and the rising number of surgical procedures are the key factors driving the market. For instance, as per a report published by ScienceDirect in 2018, the surgical infection has the highest prevalence rate of around 4.0%, followed by diabetic foot ulcers of around 3.4%. In addition, the rising number of wound care centers across the globe is expected to surge the demand for wound irrigation systems.

Moreover, the increasing incidence of burn cases across the globe is anticipated to boost the demand for the product. According to a report published by Walker Morgan, LLC, in 2017, around 450,000 Americans receive medical treatment for burn injuries every year. As per the report published by Swift Medical Inc. in 2018, more than 305.0 million acute, burn, and traumatic wounds are recorded per year globally. Furthermore, as per the data reported by the WHO, over 1,000,000 people register, annually, as moderately or severely burnt. As wound irrigation system is very much effective in burn injury and allows rapid healing, thus increasing incidence rate of burns is anticipated to propel the market growth over the forecast period.

Request a free sample copy or view report summary: Wound Irrigation System Market Report

Wound Irrigation System Market Report Highlights

• By product, the manual wound irrigation system segment held the largest market share in 2020 owing to the increasing incidence of burns and surgical site infection across the globe
• Based on application, the chronic wounds segment held the largest share in 2020 due to the rising prevalence of diabetic foot ulcers and pressure ulcers
• Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising number of diabetic patients in this region

Wound Irrigation System Market Segmentation

Grand View Research has segmented the global wound irrigation system market on the basis of the product, application, and region:

Wound Irrigation System Product Outlook (Revenue, USD Million, 2016 - 2028)

• Manual
• Battery-operated

Wound Irrigation System Application Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic Wounds
  • Diabetic Foot Ulcer
  • Pressure Ulcer
  • Venous Leg Ulcer
• Burns
• Surgical Wounds
• Traumatic Wounds

Wound Irrigation System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Wound Irrigation System Market

• Zimmer Biomet
• Stryker Corporation
• Centurion Medical Products
• BSN Medical
• Cooper Surgical Inc.
• R. Bard, Inc.
• Bionix
• Westmed, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Rhinoplasty Market Industry Analysis , Opportunity Assessment And Forecast Till 2028: Grand View Research Inc.

 Rhinoplasty Market Growth & Trends

The global rhinoplasty market size is expected to reach USD 7.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. Rhinoplasty is a type of surgery that changes the shape of the nose. It is one of the most popular types of facial plastic surgery.

The growing focus among people towards physical appearance and technological advancements in the dermatology industry are some of the key factors expected to increase the demand for nose jobs in the coming years. According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), in 2018, rhinoplasty was among the top 5 surgical procedures carried out at a global level with over 726,907 surgeries performed.

These statistics suggest that there is a huge demand for nose jobs and the rising awareness about aesthetic appeals is the most important factor contributing to market growth. The availability of skilled plastic surgeons and technological advancements such as 3D computer-assisted techniques are anticipated to further fuel the growth of the market.  

The COVID-19 pandemic has significantly affected the market. Initially, due to lockdown being imposed in most of the countries, surgeries were halted. Since rhinoplasty involves surgery of the nose, surgeons were at a higher risk of getting exposed to the virus, as the virus lives in the nose. However, recently, hospital surgery centers have put pandemic protocols to be maintained for both safety of the staff and the patients. For instance, in one of the surgery centers in the US, the patient getting tested for coronavirus 48 hours prior to any surgery, staff using N95 masks, and so forth. While cosmetic surgeries are currently being held virtually, certain emergency elective surgeries are being given approval, and that too after following strict protocols.

Request a free sample copy or view report summary: Rhinoplasty Market Report

Rhinoplasty Market Report Highlights

• Augmentation emerged as the largest segment in 2020 owing to its necessity for both functional and aesthetic indications
• Open rhinoplasty accounted for the largest revenue share in 2020 owing to its ability to alter nasal shape with precision and better facial appearance
• In Asia Pacific, the market is projected to witness a CAGR of 7.6% during the forecast period. Countries such as China and Japan are the hub of nose surgeries in the region

Rhinoplasty Market Segmentation

Grand View Research has segmented the global rhinoplasty market based on treatment type, technique, and region:

Rhinoplasty Treatment Type Outlook (Revenue, USD Million, 2016 - 2028)     

• Augmentation
• Reduction
• Post-traumatic
• Reconstructive
• Revision
• Filler
• Others (Ethnic Rhinoplasty, Refinement Rhinoplasty)        

Rhinoplasty Technique Outlook (Revenue, USD Million, 2016 - 2028)

• Open
• Closed

Rhinoplasty Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Rhinoplasty Market

• Stryker
• Grover Aesthetics
• Sunset Cosmetic Surgery
• Implantech
• GC Aesthetics
• Surgiform Technologies LLC.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Assisted Living Facility Market Size, Industry Share And Growth Analysis For 2021-2027: Grand View Research Inc.

 U.S. Assisted Living Facility Market Growth & Trends

The U.S. assisted living facility market size is expected to reach USD 119.2 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.3% from 2021 to 2027. The rising incidence of brain injury, growing geriatric population, and technological developments are expected to boost the market growth during the forecast period.

In the U.S., the assisted living facilities (ALF) provide meals, housekeeping services, social and recreational activities, and exercise and wellness programs. They also provide medical assistance in case of an emergency. Adults opting for assisted living pay for it from their savings and investments. Community service providers, household vendors, and premium elderly homes offer the required assistance and facilities to meet the daily necessities of the elderly.

The rise in the geriatric population due to the increased life expectancy is expected to grow rapidly in the future. According to the National Institute on Aging (NIA), globally, around 8.5% of the population is aged 65 years and above. As per the data published by the Population Reference Bureau, the number of Americans aged 65 years and above is projected to reach 95 million by 2060, from 52 million in 2018; by percentage, the age group of 65 years and above is expected to increase from 16% in 2018 to 23% by 2060.

Based on the nature of the population served and service provision, residents at assisted living facilities may be at a high risk of contracting COVID-19. To cope with the situation, in March 2020, CMS released guidelines for nursing homes and ALFs to help curb the spread of the novel coronavirus. These measures include prohibitions on visitors and nonessential staff, daily monitoring for symptoms, screening employees, implementing infection control and cleaning protocols, ensuring social distancing, hiring and training additional employees, adjusting activities, and paying bonuses and overtime. The majority of these facilities were not allowed to accept new residents, and therefore, had no new revenue streams for the additional expenses associated with the virus, which is hampering the market growth.

Request a free sample copy or view report summary: U.S. Assisted Living Facility Market Report

U.S. Assisted Living Facility Market Report Highlights

• The industry is witnessing dynamic mergers, acquisitions, and joint venture agreements. For instance, in July 2019, Kindred Healthcare, in a joint venture with Atlantic Health System, completed the construction of a 38-bed comprehensive inpatient rehabilitation facility - Atlantic Rehabilitation Institute — in Madison, NJ
• Key players in the U.S. market for the assisted living facility are taking up initiatives, such as merger & acquisition, joint ventures, and partnerships, in order to increase their market presence
• In August 2020, Integral Senior Living entered into a partnership with Investcor Development, along with Bow River Capital and SMC Construction, to develop a new assisted living and memory care community at Sparks, Nevada

List of Key Players of U.S. Assisted Living Facility Market

• Atria Senior Living, Inc.
• Kindred Healthcare, Inc.
• Brookdale Senior Living Solutions
• Integral Senior Living
• Five Star Senior Living
• Sunrise Senior Living, Inc.
• Merrill Gardens
• Capital Senior Living
• Gardant Management Bradley
• Belmont Village, L.P.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-invasive Aesthetic Treatment Market Outlook Growth Emerging Factors On Geography, Technological Advancements by 2028

 Non-invasive Aesthetic Treatment Market Growth & Trends

The global non-invasive aesthetic treatment market size is expected to reach USD 18.5 billion by 2028, according to a new report by Grand View Research, Inc., registering a CAGR of 13.9% over the forecast period. Non-invasive aesthetic treatment offer benefits, such as less pain, instant results, and low cost, over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging.

According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects for the market in the coming years. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.

Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the rapidly growing population in countries, such as India and China.

Request a free sample copy or view report summary: Non-invasive Aesthetic Treatment Market Report

Non-invasive Aesthetic Treatment Market Report Highlights

• Injectable procedure is projected to be the leading procedure segment over the forecast period
• Among various injectable procedures, botulinum toxin is one of the most widely used minimally invasive treatment
• North America was the dominant regional market in 2020 accounting for a share of around 37% due to the availability and adoption of advanced treatment options in this region
• Asia Pacific is projected to register the fastest CAGR over the forecast period on account of the rising target population in the region

Non-invasive Aesthetic Treatment Market Segmentation

Grand View Research has segmented the global non-invasive aesthetic treatment market on the basis of procedure and region:

Non-invasive Aesthetic Treatment Procedure Outlook (Revenue, USD Million, 2016 - 2028)

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

Non-invasive Aesthetic Treatment Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Non-invasive Aesthetic Treatment Market

• Hologic, Inc.
• Allergan, Inc.
• Galderma S.A.
• Alma Lasers
• Syneron Candela
• Johnson & Johnson
• Merz Pharma
• Lumenis
• Solta Medical
• Cutera, Inc.
• Revance Therapeutics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand Medical Affairs Outsourcing Market Increasing in Most Part of World 2028

 Medical Affairs Outsourcing Market Growth & Trends

The global medical affairs outsourcing market size is expected to reach USD 3.47 billion by 2028 registering a CAGR of 12.2%, according to a new report by Grand View Research, Inc. Transformation in medical education and the rising number of orphan therapies for the treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market. According to a report published by IQVIA in 2020, the U.S. FDA has approved 80 orphan indications in 2017 and about 57 in early 2020.

Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, the pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.

In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic. This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry.

Request a free sample copy or view report summary: Medical Affairs Outsourcing Market Report

Medical Affairs Outsourcing Market Report Highlights

• The medical writing & publishing segment led the market in 2020 and is expected to witness significant growth over the forecast period, owing to the increasing need for marketable written content to convey medical information to healthcare professionals and patients
• North America dominated the global market with a share of 35.3% in 2020 owing to the presence of a large number of pharmaceutical and medical devices companies in the region
• Moreover, the high cost of medical affairs services is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors in off-shore locations with a high level of expertise in the domain
• However, Asia Pacific is anticipated to account for the largest revenue share by 2028 while growing at the fastest CAGR over the forecast period, owing to cost-efficient service offering by the CROs in the region
• In addition, improved regulatory framework and availability of a skilled workforce in APAC boosts the market growth

Medical Affairs Outsourcing Market Segmentation

Grand View Research has segmented the global medical affairs outsourcing market on the basis of services, industry, and region:

Medical Affairs Outsourcing Services Outlook (Revenue, USD Billion, 2016 - 2028)

• Medical Writing & Publishing
• Medical Monitoring
• Medical Science Liaisons (MSLs)
• Medical Information
• Others

Medical Affairs Outsourcing Industry Outlook (Revenue, USD Billion, 2016 - 2028)

• Pharmaceutical
• Biopharmaceutical
• Medical Devices
  • Therapeutic Medical Devices
  • Diagnostic Medical Devices

Medical Affairs Outsourcing Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Medical Affairs Outsourcing Market

• ICON plc
• IQVIA Holdings, Inc.
• The Medical Affairs Company
• Syneos Health, Inc.
• Pharmaceutical Product Development, LLC
• Ashfield Healthcare Communications
• Zeincro Group
• Wuxi Clinical Development, Inc.
• SGS S.A.
• Indegene, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Tapes And Bandages Market to Witness Exponential Growth by 2028: Grand View Research Inc.

 Medical Tapes And Bandages Market Growth & Trends

The global medical tapes and bandages market size is expected to reach USD 14.44 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.5% from 2021 to 2028. The increasing number of accidents, the impact of COVID-19, and technological advancements are the key factors driving the market. 

Ambulatory surgery centers (ASCs) offer a variety of services, such as surgical care, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, reconstructive, or alterative plastic surgeries and gastrointestinal (GI)-related surgeries are also performed in ambulatory surgery centers. Earlier, ASCs were only capable of performing GI-related minor surgeries, however, with an increase in the number of minimally invasive surgical procedures, services offered by ambulatory surgical centers expanded and grew exponentially. According to the U.S. Department of Health and Human Services (HHS) data records of 2016, there were 17.2 million hospital visits. These included invasive, therapeutic surgeries, and ambulatory surgeries. Around 9.94 million (57.8%) of these surgeries occurred in hospital-owned ambulatory surgery settings and the remaining 7.26 million surgeries (42.2%) were conducted in hospitals.

ASCs are increasing in number and they offer cost-effective services. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. The chances of contracting post-surgical, hospital-related infections are also reduced. ASCs provide specific instructions to patients regarding dressing and post-surgical homecare. Thus, with an increase in the number of ASCs and the number of surgeries being performed, demand for medical tapes and bandages is expected to increase.

Request a free sample copy or view report summary: Medical Tapes And Bandages Market Report

Medical Tapes And Bandages Market Report Highlights

• Based on product, the medical bandages segment held the largest share in 2020. The rising number of road accidents across the globe is the major factor propelling the segment growth
• On the basis of application, the surgical wound segment held the largest market share in 2020 and is expected to witness considerable growth over the forecast period due to the increasing number of surgeries
• By end use, the hospitals segment held the largest market share in 2020 owing to the increasing number of hospitals
• Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising prevalence of chronic wounds

Medical Tapes And Bandages Market Segmentation

Grand View Research has segmented the global medical tapes and bandages market on the basis of product, application, end use, and region:

Medical Tapes & Bandages Product Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Tapes
  • Fabric Tapes
    • Acetate
    • Viscose
    • Cotton
    • Silk
    • Polyester
    • Other Fabric Tapes
  • Paper Tapes
  • Plastic Tapes
    • Polypropylene
    • Other Plastic Tapes
  • Other Tapes
• Medical Bandages
  • Muslin Bandage Rolls
  • Elastic Bandage Rolls
  • Triangular Bandages
  • Orthopedic Bandages
  • Elastic Plaster Bandages
  • Other Bandages

Medical Tapes & Bandages Application Outlook (Revenue, USD Million, 2016 - 2028)

• Surgical Wound
• Traumatic Wound
• Ulcer
• Sports injury
• Burn injury
• Other injuries

Medical Tapes & Bandages End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory surgery centers
• Clinics
• Retail
• Others

Medical Tapes & Bandages Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Medical Tapes & Bandages Market

• Smith & Nephew PLC
• Mölnlycke Health Care AB
• Ethicon Inc. (JOHNSON & JOHNSON)
• Medtronic
• 3M
• Beiersdorf AG
• Urgo Medical
• Dynarex Corporation
• Winner Medical Group, Inc.
• McKesson Corporation
• Cardinal Health
• 3L Medicinal Products Group
• Braun Melsungen AG
• Paul Hartmann AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Preclinical CRO Market is Estimated To Expand at a CAGR of 8.1% through 2028

 

Preclinical CRO Market Growth & Trends

The global preclinical CRO market size is expected to reach USD 8.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The market is expected to witness lucrative growth over the forecast period due to increasing R&D expenditure and growing outsourcing trend. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market growth over the forecast period.

The market is undergoing a series of mergers and acquisitions, resulting in the improvement in full-service capabilities and international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, mid-sized and smaller contract research organizations (CROs) are focusing on niche sectors and are providing a personalized approach to their sponsors. Various companies are focusing on research and development of new drugs, and therefore are outsourcing these activities to launch efficient CRO services in the market. This, in turn, provides a positive atmosphere for joint ventures among market participants owing to the preference of sponsors to maximize their benefits.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 20, 2021, more than 96.7 million cases of COVID-19 were reported globally, with more than 2,068,303 deaths across the globe. This pandemic has fast-tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in preclinical studies as well as trials.

North America held the largest share of 47.7% in 2020. Significant investment in healthcare R&D, coupled with well-developed healthcare infrastructure in the U.S., is contributing to the largest share of North America. Asia Pacific is projected to expand at the fastest CAGR of 12.0% over the forecast period.

Request a free sample copy or view report summary: Preclinical CRO Market Report

Preclinical CRO Market Report Highlights

• By service, the toxicology testing segment accounted for the largest share of 61.1% in 2020 due to its significance in Investigational New Drug (IND)-enabling studies
• Based on end-use, the government and academic institutes segment is anticipated to register the highest CAGR of 8.4% over the forecast period due to improving government initiatives toward healthcare, especially in developing economies
• North America dominated the market in 2020 with a share of 47.7%. Significant healthcare expenditure on R&D is one of the major factors driving the market in this region

Preclinical CRO Market Segmentation

Grand View Research has segmented the global preclinical CRO market on the basis of service, end-use, and region:

Preclinical CRO Service Outlook (Revenue, USD Million, 2016 - 2028)

• Bioanalysis and DMPK Studies
• Toxicology Testing
• Others

Preclinical CRO End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Biopharmaceutical Companies
• Government and Academic Institutes
• Medical Device Companies

Preclinical CRO Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

List of Key Players of Preclinical CRO Market

• Envigo Corporation
• MPI research
• Eurofins Scientific
• PRA Health Sciences, Inc.
• Wuxi AppTec
• Medpace, Inc.
• Pharmaceutical Product Development (PPD), LLC
• PARAXEL International Corporation
• ICON Plc
• Laboratory Corporation of America, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Robots Market is Expected to Grow High Due to Growing Need For Automation In Manufacturing Units by 2028

 

Pharmaceutical Robots Market Growth & Trends

The global pharmaceutical robots market size is expected to reach USD 297.4 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The growing pharmaceutical industry and numerous benefits offered by robotic systems in product manufacturing, such as improved production output and product quality, increased production flexibility, lesser space utilization, no labor turnover, low operating costs, enhanced health and safety, reduced production downtime, and better waste management, are driving the adoption of these products, thereby aiding the market growth. According to an article published by Mint in April 2020, the adoption and usage of robotic technology are expected to increase in India across all types of healthcare settings, despite their high prices, owing to the availability of a smaller number of healthcare professionals for more than 1.3 billion population.

In 2020, the traditional robots product segment accounted for the largest revenue share owing to its increasing adoption in material handling, picking and packaging, palletizing, and inspection. Collaborative robots are anticipated to register the fastest growth rate during the forecast period. Many companies are replacing traditional with collaborative robots or cobots, which is a combination of humans and robotics. The adoption of cobots is significantly increasing as they combine repetitive tasks of robots and the individual skills of humans to bring in efficiency in manufacturing processes. These machines are also cheaper and easier to operate and maintain as compared to the traditional ones.

In 2020, the picking and packaging application segment accounted for the largest revenue share and is anticipated to witness the fastest growth during the forecast period. This growth can mainly be attributed to the high demand for personalized packaging and benefits associated with this segment, including high speed, efficient track and trace, and optimum utilization of the floor space. In addition, all the traditional robotic solutions are mainly used for picking and packaging. For instance, 6-axis articulated robots such as VP-6242G and VS-068A2 developed by Denso Wave Incorporated enable picking and packaging.

In 2020, the pharmaceutical companies end-use segment accounted for the largest revenue share and is anticipated to register the fastest growth rate during the forecast period. This is attributed to the increasing usage of robotics in drug discovery and development. In addition, pharmaceutical companies are involved in developing personalized medicine, which further supports the growth of the segment. Research laboratories are anticipated to witness significant growth during the forecast period owing to the ability of these automated solutions to perform repetitive tasks, such as moving test tubes and fluids, during drug discovery-related activities, facilitating a high rate of consistency and accuracy.

In 2020, Asia Pacific dominated the market and is anticipated to register the fastest growth rate during the forecast period. The rise in the demand for the production of drugs and the development of robotic machines for performing tasks with high speed, reduced risk of contamination, accuracy, and optimum utilization of space among pharmaceutical companies is boosting the regional market growth. Moreover, a rise in the number of initiatives undertaken by the government to increase the adoption of industrial robots is further aiding the regional market growth. For instance, in 2016, the Chinese government launched the Robotics Industry Development Plan (2016-2020), aimed at promoting robot applications to a wider range of fields and attracting foreign investment, to develop 100,000 industrial robots produced by domestic technology annually by 2020.

Request a free sample copy or view report summary: Pharmaceutical Robots Market Report

Pharmaceutical Robots Market Report Highlights

• The market growth is attributed to various technological advancements and increasing investments in the robotics sector
• In terms of product, traditional robots dominated the market in 2020 owing to the availability of different types of traditional products for specific applications
• Based on application, the picking and packaging segment dominated the market in 2020 owing to a rise in demand for personalized packaging
• By end use, pharmaceutical companies dominated the market in 2020 owing to the rapid rate of drug discovery and high investments by the companies
• Asia Pacific dominated the market in 2020 owing to the booming pharmaceutical and industrial robotics market in the region

Pharmaceutical Robots Market Segmentation

Grand View Research, Inc. has segmented the global pharmaceutical robots market on the basis of product, application, end-use, and region:

Pharmaceutical Robots Product Outlook (Revenue, USD Million, 2014 - 2028)

• Traditional Robots
  • Articulated Robots
  • SCARA Robots
  • Delta/Parallel Robots
  • Cartesian Robots
  • Dual-arm Robots
• Collaborative Pharmaceutical Robots

Pharmaceutical Robots Application Outlook (Revenue, USD Million, 2014 - 2028)

• Picking and Packaging 
• Inspection of Pharmaceutical Drugs 
• Laboratory Applications

Pharmaceutical Robots End-use Outlook (Revenue, USD Million, 2014 - 2028)

• Pharmaceutical Companies
• Research Laboratories

Pharmaceutical Robots Regional Outlook (Revenue, USD Million, 2014 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Pharmaceutical Robots Market

• ABB Ltd.
• Kawasaki Heavy Industries Ltd.
• Universal Robots A/S
• FANUC America Corporation
• Yaskawa Electric Corporation
• Marchesini Group S.p.A
• Seiko Epson Corporation
• Denso Wave, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Specialty Medical Chairs Market Is Expected To Gain Significant Traction Over The Forecast Period

 Specialty Medical Chairs Market Growth & Trends

The global specialty medical chairs market size is expected to reach USD 6.05 billion by 2028 registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Increasing geriatric population is one of the major factors boosting the product adoption. As per the WHO, it is estimated that from 2025 to 2050, the older population is expected to almost double to 1.6 billion globally. According to The World Bank, the population in the Asia Pacific region is aging rapidly.

More than 211 million people aged 65 years and above were living in East Asia and Pacific in 2010. The older population is expected to grow by 22% every five years in East Asia. This shows the potential demand for geriatric chairs in the coming years. The rising prevalence of lifestyle-associated diseases, such as diabetes, obesity, chronic kidney disease, and Cardiovascular Diseases (CVDs), is also expected to augment the product demand. Furthermore, rising cases of paralysis and spinal injuries are anticipated to contribute to the market growth.

Increasing reimbursement policies and supportive regulatory frameworks in developed nations are also pushing the market growth. For instance, Medicare policies in the U.S. offer reimbursement for equipment, such as wheelchairs, recliners, and others. In addition, key market players are offering customized products to meet the various needs of doctors and patients. Rising demand for new, easy-to-use products with better facilities is expected to provide lucrative opportunities to the market participants.

The examination and treatment rate at dental, ophthalmic, and gynecology clinics has decreased significantly, which can be attributed to the lockdown imposed in various Asian countries due to the pandemic and growing preference for online consultations. Various domestic and international companies are facing major challenges in Japan and China due to the pandemic and the aftermath is expected to continue until the second half of 2021.

Moreover, the healthcare resources are currently directed toward essential medical devices and supplies. It is believed that the outbreak will lead to many changes, including preferences of the general public, leading to a decline in product demand. However, major countries in Asia, such as China and South Korea, are on a steady path to recovery. According to the Asian Development Bank, China’s growth is expected to rebound by about 7.3% by 2021.

Request a free sample copy or view report summary: Specialty Medical Chairs Market Report

Specialty Medical Chairs Market Report Highlights

• The rehabilitation product segment held the dominant share of over 40% in 2020 owing to rise in the geriatric population
• In 2020, dialysis chairs held the largest share in the examination product segment owing to the increased prevalence of chronic kidney diseases and rise in funding to centers for better equipment
• The treatment product segment is anticipated to register the fastest CAGR over the forecast period as these products are required for carrying out various treatment procedures, such as dental, and offer better comfort to patients during these procedures
• Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 owing to improving healthcare infrastructure, growing geriatric population, and rising disposable income levels

Specialty Medical Chairs Market Segmentation

Grand View Research has segmented the global specialty medical chairs market on the basis of product and region:

Specialty Medical Chairs Product Outlook (Revenue, USD Million, 2016 - 2028)

• Examination
  • Birthing
  • Cardiac
  • Blood Drawing
  • Dialysis
  • Mammography
• Treatment
  • Ophthalmic
  • ENT
  • Dental
  • Others
• Rehabilitation
  • Pediatric
  • Bariatric
  • Geriatric
  • Others

Specialty Medical Chairs Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Specialty Medical Chairs Market

• A-dec, Inc.
• ActiveAid, Inc.
• DentalEZ, Inc.
• Fresenius Medical Care AG & Co. KGaA
• Topcon Corp.
• Midmark Corp.
• Danaher (KaVo Dental GmbH)
• Dentsply Sirona
• Planmeca Oy
• Hill Laboratories Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gene Expression Market to Reflect Steadfast Expansion During 2021-2028

 Gene Expression Market Growth & Trends

The global gene expression market size is anticipated to reach USD 19.4 billion by 2028 registering a CAGR of 9.96% from 2021 to 2028, according to a new report by Grand View Research, Inc. Rise in investments for the development of alternative drug discovery approaches coupled with an increase in research activities for genetic studies is expected to drive the global market.

A rise in awareness about the potential application of genetic studies has led to an increase in investments for the development and launch of novel products. For instance, in August 2020, Lexogen GmbH launched the QuantSeq-Pool Sample-Barcoded 3’ mRNA-Seq Library Prep Kit to expedite multiplexing capacities during gene expression profiling. The company’s new QuantSeq-Pool kit also facilitates the sequencing of up to 36,864 RNA samples in parallel, thereby reducing cost and time. 

Furthermore, the decrease in cost associated with sequencing posed as a major driver in the last few years. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing per genome reduced from USD 46.77 thousand in 2010 to USD 0.689 thousand in 2020. This dramatic 98.5% decline in sequencing costs within a decade has increased research involving genomic expression profiling studies.

Request a free sample copy or view report summary: Gene Expression Market Report

Gene Expression Market Report Highlights

• cDNA synthesis & conversion dominated the process segment in 2020. High demand for personalized medicine coupled with technological advancements in sequencing techniques has enhanced the application of cDNA synthesis to produce genomic libraries
• Moreover, the introduction of systems that provide direct library synthesis has eliminated the need for prior steps, which increases revenue share
• Kits and reagents product generated the largest revenue in 2020 due to their high usage during the process
• In addition, ongoing innovation in the kits and reagents dedicated for specific applications contributes to the highest share of the segment
• High-Plex capacity is expected to register the fastest CAGR during the forecast period owing to the higher accuracy and increased application in cancer research
• RNA exp. was the largest revenue-contributing technique in 2020 owing to higher adoption of RNA exp. analysis
• Moreover, the introduction of high-throughput validation methods, such as targeted RNA sequencing, which are useful in broader screening technologies, has increased the revenue generation in the segment
• The drug discovery & development segment accounted for the largest revenue share in 2020 as Gene Exp. Signature (GES) is commonly used for the development of novel molecules for multifactorial cellular diseases like cancer, diabetes, tuberculosis, malaria, AIDS, and other infectious diseases
• North America was the dominant regional market in 2020. This can be attributed to the high adoption of advanced gene exp. technology in the region
• Major market participants, such as Thermo Fisher Scientific, Inc. and Agilent Technologies, have undertaken strategic initiatives to strengthen their position in the market
• In March 2020, Thermo Fisher Scientific, Inc. launched the PowerTrack SYBR Green PCR Master Mix for real-time PCR workflow. The product is intended to amplify targets for precise analysis

Gene Expression Market Segmentation

Grand View Research has segmented the global gene expression market on the basis of process, product, capacity, technique, application, and region:

Gene Expression Process Outlook (Revenue, USD Million, 2017 - 2028)

• Sample Collection
• Purification
• cDNA Synthesis & Conversion
• PCR Analysis
• Data Analysis & Interpretation

Gene Expression Product Outlook (Revenue, USD Million, 2017 - 2028)

• Kits & Reagents
• DNA Chip/Microarray
• Others

Gene Expression Capacity Outlook (Revenue, USD Million, 2017 - 2028)

• Low- to Mid-Plex
• High-Plex

Gene Expression Technique Outlook (Revenue, USD Million, 2017 - 2028)

• RNA Exp.
  • Northern Blotting
  • DNA Microarrays
  • PCR Techniques
  • RNA-Seq
• Promoter Analysis
  • In vitro Transcription/Nuclear Run-On Assays
  • Gel Shift Assays
  • Chromatin Immunoprecipitation (ChIP) Assays
• Protein Exp. & Posttranslational Modification Analysis
  • Western Blotting
  • 2-D Gel Electrophoresis
  • Immunoassays
  • Mass Spectrometry

Gene Expression Application Outlook (Revenue, USD Million, 2017 - 2028)

• Drug Discovery & Development
• Clinical Diagnostics
  • RNA Exp.
  • Other Techniques
• Biotechnology & Microbiology
• Others

Gene Expression Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Gene Expression Market

• QIAGEN
• Quest Diagnostics, Inc.
• Hoffmann-La Roche Ltd.
• Illumina, Inc.
• PerkinElmer, Inc.
• Bio-Rad Laboratories
• Thermo Fisher Scientific, Inc.
• Agilent Technologies
• GE Healthcare
• Promega Corp.
• Luminex Corp.
• Takara Bio, Inc.
• Danaher Corp.
• ELITechGroup
• AutoGenomics
• Biocartis NV
• IntegraGen
• Interpace Biosciences, Inc.
• Fluidigm Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

mHealth Apps Market Analysis, Industry Size, Share And New Opportunities Till 2028: Grand View Research Inc.

 

mHealth Apps Market Growth & Trends

The global mHealth apps market size is expected to reach USD 149.3 billion by 2028 and is expected to register a CAGR of 17.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing promotion of mHealth applications due to their benefits in improving the lifestyle and treatment outcomes is one of the key factors driving the growth of this market. In addition, the use of mobile health applications can facilitate better patient experience and engagement.

North America was the dominant regional market in 2020 and accounted for a revenue share of 38.8%. Various factors like rapid growth in the usage of smartphones, developments in coverage networks, increasing prevalence of chronic diseases, and rise in geriatric population are driving the market growth in North America. In addition, rising demand for health and analytics solutions has led to increased adoption of such applications by healthcare providers and others. Increasing cases of chronic conditions requiring remote monitoring and treatment also boost the demand for mobile health platforms.

In addition, the Covid-19 pandemic has led to an increased utilization of mobile health platforms across the globe. Increasing remote patient monitoring and patient data analysis and diagnosis are major factors for the adoption of mobile health applications. For instance, data published by Statista providing a comparison between the number of mHealth or medical application downloads and the peak month of the pandemic signifies that there was around 135% increase in the medical application downloads in South Korea and around 65% rise at a global level. Hence, the pandemic has boosted product adoption, thereby fueling the market growth.

Request a free sample copy or view report summary: mHealth Apps Market Report

mHealth Apps Market Report Highlights

• The global market size is anticipated to be valued at USD 149.3 billion by 2028 owing to growing product adoption for better patient engagement and care
• Based on type, the market is broadly classified into medical and fitness apps. The medical applications segment dominated the market in 2020
• This is owing to high awareness levels about such applications and preference for their use by healthcare professionals, patients, and other consumers
• Medical applications are further classified into applications, such as women’s health, medication management, personal health record, diagnostic, remote monitoring, disease management, and others
• North America led the global market in 2020; however, Asia Pacific is projected to become the fastest-growing regional market over the forecast period

mHealth Apps Market Segmentation

Grand View Research has segmented the global mHealth apps market on the basis of type and region:

mHealth Apps Type Outlook (Revenue, USD Million, 2016 - 2028)

• Fitness Apps
  • Diet & Nutrition
  • Exercise & Fitness
  • Lifestyle & Stress
• Medical Apps
  • Women’s Health
  • Personal Health Record
  • Medication Management
  • Diagnostic
  • Remote Monitoring
  • Disease Management
  • Others

mHealth Apps Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of mHealth Apps Market

• Abbott Laboratories
• Johnson and Johnson
• AstraZeneca PLC
• Hoffmann-La Roche Ltd.
• Novartis AG
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Merck and Co., Inc.
• Pfizer, Inc.
• Sanofi
• Samsung Electronics Co. Ltd.
• Qualcomm Technologies, Inc.
• Orange
• Google (Alphabet), Inc.
• Allscripts
• Airstrip Technologies, Inc.
• AT&T
• Apple, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Central Nervous System Therapeutic Market Plying for Significant Growth During 2021-2028

 Central Nervous System Therapeutic Market Growth & Trends

The global central nervous system therapeutic market size is expected to reach USD 205.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. High unmet medical needs and government initiatives to reduce the disease burden are driving the market for central nervous system (CNS) therapeutic over the forecast period. According to WHO, the global economy loses due to depression and anxiety is more than USD 1 trillion per year and rising patient base of mental health globally is expected to increase the economy loses by USD 16 trillion in 2030.

The market holds strong future growth opportunities and major players are adopting different marketing strategies such as new product development, collaborations, geographic expansion, mergers and acquisitions, and new product approval, to strengthen their positions. In February 2020, Biogen announced the investment in Sangamo’s zinc finger platform to develop therapies for Alzheimer’s disease and other neurological diseases. Similarly, the company has an agreement with Ionis Pharmaceutical for the development of drug candidates applicable across a wide range of neurological diseases.

Presence of strong pipeline products by major pharmaceutical companies such as Biogen, H. Lundbeck A/S, Eli Lilly and Company, and others are expected to accelerate market growth over the forecast period. Besides, other pharmaceutical companies are also actively involved in the development of novel therapies and investing heavily to develop effective therapeutics for the treatment of CNS associated diseases.

Most of the late phase development drugs are for the treatment of neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis. The drug candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are some of the potential drugs that could be commercialized in the next five to eight years for the treatment of various indication of neurodegenerative disorders. Apart from neurodegenerative diseases, migraine, schizophrenia, and epilepsy are the major CNS disease indications that have potential drug candidates in pipeline.

The cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing prevalence, high mortality rate, and rising demand for effective treatment are expected to fuel the growth of the market for CNS therapeutic. According to National Cancer Institute estimates, the number of new cases of CNS cancers was 23,890 whereas the number of deaths was 18,020 in the U.S. in 2020.

Pharmaceutical companies are adopting strategies such as product development, merger and acquisition, and collaboration to strengthen their position in market. For instance, Biogen has signed agreements with Ionis Pharmaceuticals, Atalanta Therapeutics, and Sangamo Therapeutics to develop novel therapeutics for the treatment of different disease indications of the central nervous system. Similarly, in January 2020, the CNS Pharmaceuticals has entered into a licensing agreement with MD Anderson Cancer Center to investigate WP1244, a designed DNA-binding agent to cross the blood-brain barriers for the potential treatment of brain cancers.

Request a free sample copy or view report summary: Central Nervous System Therapeutic Market Report

Central Nervous System Therapeutic Market Report Highlights

• The neurodegenerative diseases segment accounted for the largest revenue share of nearly 40.0% in 2020 and is anticipated to maintain its dominance over the forecast period
• Pipeline candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are anticipated to drive the neurodegenerative disorder segment from 2021 to 2028
• The CNS cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing demand for effective treatment is expected to drive the segment
• In Asia Pacific, the market is estimated to witness the fastest growth over the coming years owing to the increase in treatment rate and betterment of healthcare infrastructure in the region
• North America held a majority of share in 2020 due to high awareness level in the region and better reimbursement scenario

Central Nervous System Therapeutic Market Segmentation

Grand View Research has segmented the global central nervous system therapeutic market on the basis of disease and region:

CNS Therapeutic Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Neurovascular Diseases
• CNS Trauma
• Mental Health
  • Anxiety Disorders
  • Epilepsy
  • Mood Disorders
  • Psychotic Disorders
  • Others
• Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis
  • Others
• Infectious Diseases
• CNS Cancer
• Others

CNS Therapeutic Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Central Nervous System Therapeutic Market

• Biogen
• Otsuka Pharmaceutical Co., Ltd.
• Eli Lilly and Company
• Merck & Co.
• Astra Zeneca
• Shire PLC
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson Services, Inc.
• Pfizer, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Ophthalmic Drugs Market During 2021– 2028 to Gain Robust Traction: Grand View Research Inc.

 Ophthalmic Drug Market Growth & Trends

The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050.

Moreover, due to COVID-19, it has become increasingly unsafe for individuals to touch their face several times a day, which is a known cause of transmission. Therefore, companies are developing long-acting, hands-free therapies to combat such challenges. For instance, in April 2020, Ocular Therapeutix, Inc. completed Phase III clinical trial to evaluate the safety and efficacy of DEXTENZA for allergic conjunctivitis. It is a hands-free therapy administered in the office setting as an intracanalicular insert. It is bioresorbable and designed to release the corticosteroid dexamethasone to the ocular surface, lasting 30 days. It is a one-time and long-acting therapy that can be useful during the COVID-19 crisis.

Investors are increasingly funding companies to support the clinical development of novel treatments for eye diseases thereby fueling the market growth. For instance, in February 2019, Oyster Point Pharma, Inc. received USD 93 million series B financing from Invus Opportunities, Flying L Partners, New Enterprise Associates (NEA), Versant Ventures, and Vida Ventures. The company’s product candidates include OC-01 and OC-02 in a Phase 2b clinical trial.

In addition, increasing development and approval of new laboratory methods is expected to boost the market growth. For instance, in July 2020, Quest Diagnostics received emergency Use Authorization (EUA) from the U.S. FDA for a laboratory technique that was developed for extracting viral RNA. This new technique was designed to expand the testing capacity of COVID-19 molecular tests.

Furthermore, key players in the market undertake various strategies to strengthen their product portfolios and offer diverse, technologically advanced, and innovative products. For instance, in September 2019, Alcon introduced iLUX Patient Care Kits to support practices in treating people with dry eyes in the U.S.

Request a free sample copy or view report summary: Ophthalmic Drug Market Report

Ophthalmic Drug Market Report Highlights

• In 2020, anti-VEGF agents dominated the market owing to high preference by ophthalmologists, enhanced tissue penetration, and rapid responsive rates
• Retinal disorders was the fastest-growing disease segment in 2020 owing to an increase in the prevalence of age-related macular degeneration and diabetic retinopathy, technological advancements, and rising strategic collaborations
• The topical route of administration dominated the market in 2020 due to the high patient compliance, non-invasiveness, and self-administrability
• The eye drops segment is estimated to witness the fastest growth over the forecast period due to impending launches of several ophthalmic solutions and suspensions in the near future and its direct drug delivery mechanism
• North America dominated the market and accounted for the largest revenue share in 2020 owing to the rising consumer awareness, high disease burden, technological advancements, and proactive government measures

Ophthalmic Drug Market Segmentation

Grand View Research has segmented the global ophthalmic drugs market on the basis of drug class, disease, dosage form, route of administration, product type, and region.

Ophthalmic Drugs Class Outlook (Revenue, USD Million, 2017 - 2028)

• Antiallergy
• Anti-VEGF Agents
• Anti-inflammatory
  • Nonsteroidal Drugs
  • Steroidal Drugs
• Antiglaucoma
• Others

Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Dry Eye
• Eye Allergy
• Glaucoma
• Eye Infection
• Retinal Disorders
  • Macular Degeneration
  • Diabetic Retinopathy
  • Others
• Uveitis
• Others

Ophthalmic Drugs Dosage Form Outlook (Revenue, USD Million, 2017 - 2028)

• Gels
• Eye Solutions
• Capsules & Tablets
• Eye Drops
• Ointments

Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2017 - 2028)

• Topical
• Local Ocular
  • Subconjunctival
  • Intravitreal
  • Retrobulbar
  • Intracameral
• Systemic

Ophthalmic Drugs Product Type Outlook (Revenue, USD Million, 2017 - 2028)

• Prescription Drugs
• OTC Drugs

Ophthalmic Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Ophthalmic Drugs Market

• Alcon
• Johnson & Johnson Services, Inc.
• Bausch Health
• Allergan
• Pfizer, Inc.
• Bayer AG
• Santen Pharmaceutical Co. Ltd.
• Genentech, Inc.
• Novartis AG
• Regeneron
• Merck & Co.
• Coherus Biosciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.